Janus Henderson Group PLC Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janus Henderson Group PLC trimmed its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 15.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,389,767 shares of the medical instruments supplier’s stock after selling 1,172,600 shares during the period. Janus Henderson Group PLC owned approximately 3.21% of DENTSPLY SIRONA worth $172,907,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Scientech Research LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $846,000. VELA Investment Management LLC purchased a new stake in DENTSPLY SIRONA during the 3rd quarter valued at $2,168,000. M&G Plc bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $8,817,000. Empowered Funds LLC purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth $2,468,000. Finally, Country Club Bank purchased a new stake in DENTSPLY SIRONA during the third quarter valued at $4,084,000. Institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

XRAY has been the subject of a number of recent research reports. Evercore ISI cut their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Robert W. Baird decreased their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $29.22.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $19.39 on Wednesday. The stock has a 50-day moving average price of $22.29 and a 200 day moving average price of $24.62. The stock has a market capitalization of $3.85 billion, a P/E ratio of -9.37, a P/E/G ratio of 1.94 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period last year, the firm posted $0.49 EPS. The company’s revenue was up .4% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.